SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
研友_LB1wg8
Lv1
80 积分
2020-05-24 加入
最近求助
最近应助
互助留言
ROSEWOOD: A Phase II Randomized Study of Zanubrutinib Plus Obinutuzumab Versus Obinutuzumab Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma
1个月前
已完结
Feline Gastrointestinal Lymphoma
1个月前
已完结
Overview of Lymphoma Diagnosis and Management
1个月前
已完结
Ibrutinib, rituximab, and lenalidomide in unfit or frail patients aged 75 years or older with de novo diffuse large B-cell lymphoma: a phase 2, single-arm study
2个月前
已完结
Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma
4个月前
已完结
Long-term Outcomes in Primary CNS Lymphoma Following R-MVP and High Dose Chemotherapy With Autologous Hematopoietic Stem Cell Transplant
7个月前
已完结
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit CLL patients
7个月前
已完结
Final analysis of the CLL2-GIVe trial (obinutuzumab, ibrutinib, and venetoclax) in untreated CLL with del(17p)/TP53mut
7个月前
已完结
Detailed safety profile of acalabrutinib vs ibrutinib in previously treated chronic lymphocytic leukemia in ELEVATE-RR
7个月前
已完结
Sustained remissions in CLL after frontline FCR treatment with very long-term follow-up
7个月前
已完结
没有进行任何应助
文章不对
2年前
错误文献
2年前
标题应该是Tislelizumab for the treatment of classical Hodgkin's lymphoma
3年前
好的,谢谢
3年前
文章不对
3年前
感谢
3年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论